TTI-622

Trillium Therapeutics Doses First Patient With Checkpoint Inhibitor TTI-622
CP Wire
Thu, 06/14/18 - 10:11 am
Trillium Therapeutics
TTI-622
cancer immunotherapies
Trillium Therapeutics Doses First Patient With Checkpoint Inhibitor TTI-622
Thu, 06/14/18 - 10:07 am
Trillium Therapeutics
TTI-622
cancer immunotherapies